Freenome Holdings Inc. has raised $270 million to pursue U.S. regulatory approval of a blood test to detect colorectal cancer, part of a push by molecular-testing companies to enable earlier cancer diagnosis and treatment.
Freenome Holdings Inc. has raised $270 million to pursue U.S. regulatory approval of a blood test to detect colorectal cancer, part of a push by molecular-testing companies to enable earlier cancer diagnosis and treatment.
General Atlantic and Sequoia Capital, two top investors in TikTok’s Chinese parent company, are vying to be part of a deal for the U.S. operations of the video-sharing app.
Progress in fields such as next-generation sequencing, gene editing and artificial intelligence is creating opportunities for entrepreneurs to create new types of treatments, digital-health services and diagnostics, and Civilization helps these kinds of companies get their start.
Unity Software, which develops software used to design videogames, counts Sequoia Capital and Silver Lake as backers.
WSJ Pro is tracking return multiples for investments in venture-backed technology companies that have gone public.
WSJ Pro looks into which body systems benefit most from venture investments.